| Address: | 1 Deerpark Dr # G, Monmouth Junction, NJ 08852, USA |
|---|---|
| Postal code: | 08852 |
| Phone: | (732) 246-8676 |
| Website: | http://www.tyrx.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about TYRX, Inc., use the form below and your opinion, advice or comment will appear in this space.
TYRX, Inc. was formerly known as TYRX Pharma, Inc. The company was founded in 1998 and is based in Monmouth Junction, New Jersey. As of December 30, 2013, TYRX, Inc. operates as a subsidiary of ...
Phone: 732-246-8676 About the Company TYRX delivers site-specific therapy by commercializing proprietary, implantable medical-pharmaceutical combination devices for the surgical markets.
View company leaders and background information for Tyrx, Inc. Search our database of over 100 million company and executive profiles. ... (732)246-8676. Overview. 30.
Phone: (732) 246-8676 Description: TYRX, Inc. is a global leader in the development and manufacturing of innovative, implantable, combination drug+device products that utilize novel biomaterials. TYRX is committed to expanding...
TYRX, Inc. is a global leader in the development and manufacturing of innovative, implantable, combination drug+device products that utilize novel biomaterials. Since its inception, TYRX has been dedicated to identifying and resolving unmet needs in the healthcare sector through evolutionary thinking and imaginative development.
(732) 246-8676. www.tyrx.com. ... D&B Hoovers provides sales leads and sales intelligence data on over 120 million companies like Tyrx, Inc. and Surgical appliances ...
TYRX, Inc. designs and develops medical and pharmaceutical devices. The Company delivers site-specific therapy by commercializing proprietary, implantable medical pharmaceutical combination ...
TYRX, Inc. Robert White, 732-246-8676 President and Chief Executive Officer info@TYRX.com or For Media: Kureczka/Martin Associates Joan Kureczka, 415-690-0210 Joan@Kureczka-Martin.com Help employers find you! Check out all the jobs and post your resume.
Zero Infections in High-Risk Cardiac Device Replacements Reported with Use of TYRX Antibacterial Envelope . Prospective, Multicenter Study of 532 Case Matched Patients Showed . 100% Reduction in Infections . Athens, Greece (June 26, 2013): Use of TYRX, Inc.'s AIGISRx® Antibacterial Envelope
TYRX, Inc. Robert White, 732-246-8676 President and Chief Executive Officer info@TYRX.com. Release Summary. TYRX®, Inc. announced that the CMS issued a new ICD-9-CM procedure code for hospital ...